e-learning
resources
Virtual 2020
Pre-Congress Content
Diagnosis and management of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The 'surprise question' in patients surviving severe COPD exacerbation.
S. Gillespie (Newcastle Upon Tyne, United Kingdom), N. Lane (Newcastle Upon Tyne, United Kingdom), C. Echevarria (Newcastle Upon Tyne, United Kingdom), K. Frew (Newcastle Upon Tyne, United Kingdom), S. Bourke (Newcastle Upon Tyne, United Kingdom)
Source:
Virtual Congress 2020 – Diagnosis and management of COPD
Session:
Diagnosis and management of COPD
Session type:
E-poster session
Number:
109
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Gillespie (Newcastle Upon Tyne, United Kingdom), N. Lane (Newcastle Upon Tyne, United Kingdom), C. Echevarria (Newcastle Upon Tyne, United Kingdom), K. Frew (Newcastle Upon Tyne, United Kingdom), S. Bourke (Newcastle Upon Tyne, United Kingdom). The 'surprise question' in patients surviving severe COPD exacerbation.. 109
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Clinical and inflammatory characteristics of 'unreported' COPD exacerbations
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
A typical COPD exacerbation?
Source: Breathe 2008; 4: 346-354
Year: 2008
Sputum characteristics of stable COPD patients after a first admission for an exacerbation. The "phenotype and course of COPD" (PAC-COPD) study
Source: Eur Respir J 2006; 28: Suppl. 50, 549s
Year: 2006
Early discharge for patients with exacerbations of COPD - a real life cohort study
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005
LATE-BREAKING ABSTRACT: The prevalence of night and morning symptoms in primary care COPD patients: How do they relate to COPD health status and disease severity? An UNLOCK study
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015
The last year of life of chronic obstructive pulmonary disease (COPD) patients: a qualitative study of carers' accounts
Source: Eur Respir J 2001; 18: Suppl. 33, 348s
Year: 2001
LATE-BREAKING ABSTRACT: Can patients with COPD assimilate disease specific information at a time of being acutely unwell due to an exacerbation of their disease?
Source: International Congress 2016 – Best abstracts on innovative outcomes and novel interventions in respiratory physiotherapy
Year: 2016
Patients' experiences of asthma exacerbation and management: a qualitative study of severe asthma
Source: ERJ Open Res, 7 (2) 00528-2020; 10.1183/23120541.00528-2020
Year: 2021
A survey of COPD patients' understanding and perception of their disease
Source: Eur Respir J 2002; 20: Suppl. 38, 622s
Year: 2002
Can we predict who is mostly likely to re-exacerbate after a COPD exacerbation?
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?”
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Is high level of IgE an additional problem in smoking patients with severe and very severe chronic obstructive pulmonary disease (COPD)?
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012
Factors affecting patients' reporting of COPD exacerbations
Source: Eur Respir J 2001; 18: Suppl. 33, 487s
Year: 2001
Can we consider the "frequent exacerbator" a reliable COPD phenotype?
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
FEV1 decline in patients with chronic obstructive pulmonary disease: Which treatment option is better for slowing of decline?
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
A global survey conducted to determine frequency of exacerbations in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Comparison of COPD patients with high and low symptoms from a real-world US survey
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
Deprescribing of inhaled corticosteroids in patients with COPD with mild or moderate airflow limitation: what do patients think?
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept